Immunoglobin From Chinese Maker Involved In Six Deaths
This article was originally published in PharmAsia News
Executive Summary
A batch of immunoglobin produced by Jiangxi Yabo Biopharmaceutical of China may have caused of the deaths of six hospital patients. Health authorities ordered sales and use of the JYBC immunoglobin suspended and urged the firm to recall the entire batch. In addition, local authorities sealed all JYBC immunoglobin until samples can be tested. The injections were given during the past week at a Nanchang University-affiliated hospital in East China. (Click here for more